PuSH - Publikationsserver des Helmholtz Zentrums München

Vojnic, E.* ; Mourao, A. ; Seizl, M.* ; Simon, B.* ; Wenzeck, L.* ; Larivière, L.* ; Baumli, S.* ; Baumgart, K.* ; Meisterernst, M.* ; Sattler, M. ; Cramer, P.*

Structure and VP16 binding of the Mediator Med25 activator interaction domain.

Nat. Struct. Mol. Biol. 18, 404-410 (2011)
Verlagsversion DOI PMC
Open Access Gold
Eukaryotic transcription is regulated by interactions between gene-specific activators and the coactivator complex Mediator. Here we report the NMR structure of the Mediator subunit Med25 (also called Arc92) activator interaction domain (ACID) and analyze the structural and functional interaction of ACID with the archetypical acidic transcription activator VP16. Unlike other known activator targets, ACID forms a seven-stranded β-barrel framed by three helices. The VP16 subdomains H1 and H2 bind to opposite faces of ACID and cooperate during promoter-dependent activated transcription in a in vitro system. The activator-binding ACID faces are functionally required and conserved among higher eukaryotes. Comparison with published activator structures reveals that the VP16 activation domain uses distinct interaction modes to adapt to unrelated target surfaces and folds that evolved for activator binding.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
13.685
2.614
39
75
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Herpes-simplex-virus; RNA-polymerase-II; Transcriptional activation; Transactivation domain; Regulatory protein; Mammalian-cells; DNA-binding; Basal transcription; Cross-Linking; Amino-acids
Sprache englisch
Veröffentlichungsjahr 2011
HGF-Berichtsjahr 2011
ISSN (print) / ISBN 1545-9993
e-ISSN 1545-9985
Quellenangaben Band: 18, Heft: 4, Seiten: 404-410 Artikelnummer: , Supplement: ,
Verlag Nature Publishing Group
Verlagsort New York, NY
Begutachtungsstatus Peer reviewed
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-503000-001
PubMed ID 21378965
Scopus ID 79953770655
Erfassungsdatum 2011-09-20